Losartan protects liver against ischaemia/reperfusion injury through PPAR-γ activation and receptor for advanced glycation end-products down-regulation

The Neuroprotective Effect of Losartan through Inhibiting AT1/ASK1/MKK4/JNK3 Pathway Following Cerebral I/R in Rat Hippocampal CA1 Region

(2012) Tian-Ling Zhang et al.   CNS Neuroscience & Therapeutics

Structural basis for telmisartan-mediated partial activation of PPAR gamma

(2012) Yasushi Amano et al.   HYPERTENSION RESEARCH

Guide to Receptors and Channels (GRAC), 5th edition

(2011) SPH Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes

(2011) S. N. Goyal et al.   DIABETES OBESITY & METABOLISM

Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-γ activation in human monocytes

(2011) Tao Pang et al.   JOURNAL OF HYPERTENSION

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

(2010) JC McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage

(2010) Masatsugu Horiuchi et al.   BRITISH JOURNAL OF PHARMACOLOGY

Losartan inhibits LPS-induced inflammatory signaling through a PPARγ-dependent mechanism in human THP-1 macrophages

(2010) Jianbo An et al.   HYPERTENSION RESEARCH

The angiotensin II type 1 receptor antagonist Losartan binds and activates bradykinin B2 receptor signaling

(2010) Marie Mi Bonde et al.   REGULATORY PEPTIDES

Ligand-Activated Peroxisome Proliferator–Activated Receptor-γ Protects Against Ischemic Cerebral Infarction and Neuronal Apoptosis by 14-3-3ε Upregulation

(2009) Jui-Sheng Wu et al.   CIRCULATION

Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury

(2009) Shan Zeng et al.   JOURNAL OF HEPATOLOGY

Effect of angiotensin II and bradykinin inhibition in rat reduced-size liver transplantation

(2009) Susagna Padrissa-Altés et al.   LIVER TRANSPLANTATION

Fat and Beyond: The Diverse Biology of PPARγ

(2008) Peter Tontonoz et al.   Annual Review of Biochemistry

Oxygen Deprivation Triggers Upregulation of Early Growth Response-1 by the Receptor for Advanced Glycation End Products

(2008) Jong Sun Chang et al.   CIRCULATION RESEARCH

Advanced Glycation End Products (AGEs) and their Involvement in Liver Disease

(2008) Hideyuki Hyogo et al.   CURRENT PHARMACEUTICAL DESIGN

RAGE and Modulation of Ischemic Injury in the Diabetic Myocardium

(2008) L. G. Bucciarelli et al.   DIABETES

Are Angiotensin II Receptor Antagonists Useful Strategies in Steatotic and Nonsteatotic Livers in Conditions of Partial Hepatectomy under Ischemia-Reperfusion?

(2008) F. S. Ramalho et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Activation of Peroxisome Proliferator-Activated Receptor-γ During Hepatic Ischemia Is Age-Dependent

(2008) Thomas Shin et al.   JOURNAL OF SURGICAL RESEARCH